Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05655325 · ClinicalTrials.gov registry record · NA

Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity

A NA study of Mild Cognitive Impairment and Chronic Kidney Diseases, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
144
Enrollment target
1
Study location

NCT05655325: Recruiting NA study of Mild Cognitive Impairment and Chronic Kidney Diseases, sponsored by Columbia University.

NCT05655325 is a NA study of Mild Cognitive Impairment and Chronic Kidney Diseases that is actively recruiting participants, run by Columbia University. The registered enrollment target is 144 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05655325, a NA study of Mild Cognitive Impairment and Chronic Kidney Diseases, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
144 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see if 6 months of home-based walking will improve memory, and brain structure and function, compared to health education in older adults that have chronic kidney disease and mild cognitive impairment.

Primary Outcome

Composite score from Phonemic and Semantic Fluency total correct words; Trail Making Test Part B (TMT-B) time to completion; Digit Span subtest backwards total score. The composite executive functioning score will be created by converting these four individual executive cognitive scores (phonemic and Semantic fluency score), digit span backward subtest, and trail making test part B (following directionality conversion)) to standardized z scores and then averaging the standardized z scores. Z-sco

Conditions Studied

Mild Cognitive Impairment Chronic Kidney Diseases

Interventions

  • OTHER Attention control
  • BEHAVIORAL Home-based walking exercise

Study Locations (1)

New York

  • Columbia University - New York

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2024-06-18
Est. Completion 2027-02-01
Phase NA
Columbia University

958 total trials

What NCT05655325 shows while recruiting

NCT05655325 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (89% lower).

The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Attention control is the first listed.

NCT05655325 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05655325 about?

NCT05655325 is a clinical study titled "Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity". The purpose of this study is to see if 6 months of home-based walking will improve memory, and brain structure and function, compared to health education in older adults that have chronic kidney disease and mild cognitive impairment.

What is the current status of trial NCT05655325?

This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2024-06-18. Estimated completion is 2027-02-01.

What conditions does trial NCT05655325 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Chronic Kidney Diseases.

What interventions are being tested in trial NCT05655325?

The interventions under investigation include: Attention control (OTHER), Home-based walking exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT05655325?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05655325 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05655325's enrollment target sits among peer trials

144 71st of 205 higher than 133 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05655325

Source: ClinicalTrials.gov NCT05655325, the US trial registry maintained by the National Library of Medicine. NCT05655325 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.